115 related articles for article (PubMed ID: 12798973)
21. Role for the cholecystokinin-A receptor in fever: a study of a mutant rat strain and a pharmacological analysis.
Ivanov AI; Kulchitsky VA; Romanovsky AA
J Physiol; 2003 Mar; 547(Pt 3):941-9. PubMed ID: 12562931
[TBL] [Abstract][Full Text] [Related]
22. Effects of amylin on feeding of goldfish: interactions with CCK.
Thavanathan R; Volkoff H
Regul Pept; 2006 Jan; 133(1-3):90-6. PubMed ID: 16239037
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin and satiation with alcohol.
Kulkosky PJ; Sanchez MR; Foderaro MA; Chiu N
Alcohol; 1989; 6(5):395-402. PubMed ID: 2818843
[TBL] [Abstract][Full Text] [Related]
24. Oral glucose ingestion stimulates cholecystokinin release in normal subjects and patients with non-insulin-dependent diabetes mellitus.
Hasegawa H; Shirohara H; Okabayashi Y; Nakamura T; Fujii M; Koide M; Otsuki M
Metabolism; 1996 Feb; 45(2):196-202. PubMed ID: 8596489
[TBL] [Abstract][Full Text] [Related]
25. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1992 May; 106(1):61-6. PubMed ID: 1504732
[TBL] [Abstract][Full Text] [Related]
26. Exogeneous and endogenous CCK inhibit ethanol ingestion in Sardinian alcohol-preferring rats.
Geary N; Wolfe A; Polidori C; Policani F; Massi M
Peptides; 2004 Jul; 25(7):1185-94. PubMed ID: 15245879
[TBL] [Abstract][Full Text] [Related]
27. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK.
Moran TH; Ameglio PJ; Schwartz GJ; McHugh PR
Am J Physiol; 1992 Jan; 262(1 Pt 2):R46-50. PubMed ID: 1733339
[TBL] [Abstract][Full Text] [Related]
28. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin.
González-Puga C; García-Navarro A; Escames G; León J; López-Cantarero M; Ros E; Acuña-Castroviejo D
J Pineal Res; 2005 Oct; 39(3):243-50. PubMed ID: 16150104
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of either cholecystokinin receptor subtype reduces while antagonists potentiate or sensitize a morphine-induced excitatory response.
Felicio LF; Mazzini BK; Cacheiro RG; Cruz TN; Flório JC; Nasello AG
Peptides; 2001 Aug; 22(8):1299-304. PubMed ID: 11457524
[TBL] [Abstract][Full Text] [Related]
31. Role of cholecystokinin in the anorexia produced by duodenal delivery of glucose in rats.
Woltman T; Reidelberger R
Am J Physiol; 1996 Dec; 271(6 Pt 2):R1521-8. PubMed ID: 8997348
[TBL] [Abstract][Full Text] [Related]
32. Intracerebroventricular injection of CCK reduces operant sugar intake in pigs.
Baldwin BA; Sukhchai S
Physiol Behav; 1996 Jul; 60(1):231-3. PubMed ID: 8804668
[TBL] [Abstract][Full Text] [Related]
33. Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function.
Varga G; Kordás K; Burghardt B; Gacsályi I; Szénási G
Eur J Pharmacol; 1999 Feb; 367(2-3):315-23. PubMed ID: 10079007
[TBL] [Abstract][Full Text] [Related]
34. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.
Weatherford SC; Chiruzzo FY; Laughton WB
Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921
[TBL] [Abstract][Full Text] [Related]
35. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
Lu L; Zhang B; Liu Z; Zhang Z
Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
[TBL] [Abstract][Full Text] [Related]
36. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide.
Romański KW
J S Afr Vet Assoc; 2007 Dec; 78(4):209-14. PubMed ID: 18507220
[TBL] [Abstract][Full Text] [Related]
37. Peripheral apelin-13 administration inhibits gastrointestinal motor functions in rats: The role of cholecystokinin through CCK
Bülbül M; Sinen O; Birsen İ; Izgüt-Uysal V
Neuropeptides; 2017 Jun; 63():91-97. PubMed ID: 28012561
[TBL] [Abstract][Full Text] [Related]
38. Loxiglumide, L-364,718 and L-365,260 prevent the inhibition of spontaneous acetylcholine release from the frontal cerebral cortex of freely moving rat peripherally administered with cholecystokinin-8S.
Kimura I; Wakasono S; Kimura M
Jpn J Pharmacol; 1995 May; 68(1):129-32. PubMed ID: 7494376
[TBL] [Abstract][Full Text] [Related]
39. Dose-additive inhibition of intake of ethanol by cholecystokinin and bombesin.
Kulkosky PJ; Glazner GW
Alcohol Clin Exp Res; 1988 Apr; 12(2):277-81. PubMed ID: 3287991
[TBL] [Abstract][Full Text] [Related]
40. Peripheral factors in the mediation of cholecystokinin-induced satiety as assessed by comparative potencies of cholecystokinin antagonists.
Murphy RB; Smith GP; Schneider LH; Gibbs J
Peptides; 1992; 13(1):77-81. PubMed ID: 1620660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
